Showing results (401-410 of 715) with videos related to
Sort By:
Pageof 72
Human Molecular Genetics|December 4, 2012
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastomaPedro M Costa, Ana L Cardoso, Clévio Nóbrega, et al.Arthritis and Rheumatism|October 29, 2005
Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritisPauline Ho, Ian N Bruce, Alan Silman, et al.Journal of Neurosurgery|April 28, 2018
Effectiveness of perioperative antiepileptic drug prophylaxis for early and late seizures following oncologic neurosurgery: a meta-analysisEvan F Joiner, Brett E Youngerman, Taylor S Hudson, et al.BMC Research Notes|May 12, 2009
Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosisPhilip W Pemberton, Yasmeen Ahmad, Helena Bodill, et al.Pituitary|June 28, 2007
Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remissionPamela U Freda, Wendy K Chung, Naoki Matsuoka, et al.Neurosurgery|November 15, 2013
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case seriesBrad E Zacharia, Anthony P Gulati, Jeffrey N Bruce, et al.Neuropathology and Applied Neurobiology|October 31, 2020
Gonadotroph tumours with a low SF-1 labelling index are more likely to recur and are associated with enrichment of the PI3K-AKT pathwayRichard A Hickman, Jeffrey N Bruce, Marc Otten, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2017
Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to TherapyOrin Bloch, Michael Lim, Michael E Sughrue, et al.Clinical Rheumatology|January 25, 2012
Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales: addressing treatment outside the current NICE guidanceYee Chiu, Andrew J K Ostor, Anthony Hammond, et al.ACR Open Rheumatology|June 15, 2026
Long-Term Anifrolumab Treatment Normalizes Hematologic Parameters and Several Serologic Markers in Patients With Systemic Lupus ErythematosusEdward M Vital, Zahir Amoura, Kenneth C Kalunian, et al.Pageof 72